BridgeBio Pharma pioneers a 'moneyball for biotech' approach, pooling projects and promising early-stage research from academia under one financial umbrella to reduce risk and unleash innovation. The company builds bridges to groundbreaking advancements in rare disease and develops life-changing medicines for patients with unmet needs.
